Cuauhtli Azotla Vilchis

Dr. Cuauhtli Azotla Vilchis

GENOS MÉDICA Centro Especializado en Genética
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
DDDiana M. Dincã
Diana M. Dincã
LLLouison Lallemant
Louison Lallemant
AGAnchel González-Barriga
Anchel González-Barriga
NCNoémie Cresto
Noémie Cresto
SBSandra O. Braz
Sandra O. Braz
MGMário Gomes-Pereira
Mário Gomes-Pereira
Brain dysfunction in myotonic dystrophy type 1 (DM1), the prototype of toxic RNA disorders, has been mainly attributed to neuronal RNA misprocessing, while little attention has been given to non-neuronal brain cells. Here, using a transgenic mouse model of DM1 that expresses mutant RNA in various brain cell types (neurons, astroglia, and oligodendroglia), we demonstrate that astrocytes exhibit impaired ramification and polarization in vivo and defects in adhesion, spreading, and migration. RNA-dependent toxicity and phenotypes are also found in human transfected glial cells. In line with the cell phenotypes, molecular analyses reveal extensive expression and accumulation of toxic RNA in astrocytes, which result in RNA spliceopathy that is more severe than in neurons. Astrocyte missplicing affects primarily transcripts that regulate cell adhesion, cytoskeleton, and morphogenesis, and it is confirmed in human brain tissue. Our findings demonstrate that DM1 impacts astrocyte cell biology, possibly compromising their support and regulation of synaptic function.

26 January 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
CVCuauhtli Azotla Vilchis
Cuauhtli Azotla Vilchis
DSDaniel Sanchez-Celis
Daniel Sanchez-Celis
LALuis E. Agonizantes-Juárez
Luis E. Agonizantes-Juárez
RSRocío Suárez-Sánchez
Rocío Suárez-Sánchez
JHJose Manuel Hernandez
Jose Manuel Hernandez
Oscar Hernández-HernándezOscar Hernández-Hernández
Oscar Hernández-Hernández
Myotonic dystrophy type 1 (DM1), the most frequent inherited muscular dystrophy in adults, is caused by the CTG repeat expansion in the 3′UTR of the DMPK gene. Mutant DMPK RNA accumulates in nuclear foci altering diverse cellular functions including alternative splicing regulation. DM1 is a multisystemic condition, with debilitating central nervous system alterations. Although a defective neuroglia communication has been described as a contributor of the brain pathology in DM1, the specific cellular and molecular events potentially affected in glia cells have not been totally recognized. Thus, to study the effects of DM1 mutation on glial physiology, in this work, we have established an inducible DM1 model derived from the MIO-M1 cell line expressing 648 CUG repeats. This new model recreated the molecular hallmarks of DM1 elicited by a toxic RNA gain-of-function mechanism: accumulation of RNA foci colocalized with MBNL proteins and dysregulation of alternative splicing. By applying a microarray whole-transcriptome approach, we identified several gene changes associated with DM1 mutation in MIO-M1 cells, including the immune mediators CXCL10, CCL5, CXCL8, TNFAIP3, and TNFRSF9, as well as the microRNAs miR-222, miR-448, among others, as potential regulators. A gene ontology enrichment analyses revealed that inflammation and immune response emerged as major cellular deregulated processes in the MIO-M1 DM1 cells. Our findings indicate the involvement of an altered immune response in glia cells, opening new windows for the study of glia as potential contributor of the CNS symptoms in DM1.

19 October 2021 in Research Square
Verified
Preprint
Open access
PDF file
DDDiana Dincã
Diana Dincã
AGAnchel González-Barriga
Anchel González-Barriga
GSGeraldine Sicot
Geraldine Sicot
LLLouison Lallemant
Louison Lallemant
LPLaure-Elise Pillet
Laure-Elise Pillet
MGMário Gomes-Pereira
Mário Gomes-Pereira
Brain dysfunction in myotonic dystrophy type 1 (DM1), the prototype of toxic RNA disorders, has been mainly attributed to neuronal RNA misprocessing, while little attention has been given to non-neuronal brain cells. Using a transgenic mouse model of DM1 that expresses mutant RNA in various brain cell types, we demonstrate that astrocytes exhibit impaired ramification and polarization in vivo and defects in adhesion, spreading and migration. RNA-dependent toxicity and phenotypes was also found in human transfected glial cells. In line with the cell phenotypes, molecular analyses revealed extensive expression and accumulation of toxic RNA in astrocytes, which resulted in RNA spliceopathy that was remarkably more severe than in neurons. Astrocyte missplicing affected primarily transcripts that regulate cell adhesion, cytoskeleton and morphogenesis, and it was confirmed in human brain tissue. We demonstrate for the first time that DM1 impacts astrocyte cell biology, possibly compromising their support and regulation of synaptic function.

21 November 2024 in Clinical Pediatrics
Verified
Journal Article
Closed access
ACAgustín Cámara-Domínguez
Agustín Cámara-Domínguez
ASAlexandra Margaret Stuart-Aguiar
Alexandra Margaret Stuart-Aguiar
NFNicte-Há Asunción Fuentes-Canto
Nicte-Há Asunción Fuentes-Canto
ACAndrea Cervera-Rosado
Andrea Cervera-Rosado
CVCuauhtli Azotla Vilchis
Cuauhtli Azotla Vilchis
SCSilvina Noemí Contreras-Capetillo
Silvina Noemí Contreras-Capetillo
Chromosomal rearrangements are structural anomalies that affect chromosomal architecture and can impact gene expression, genomic imprinting, or even generate de novo gene fusions, as seen in hematological chromosomal aberrations. Chromosomal rearrangements can be associated with syndromes causing neurodevelopmental delay, autism spectrum disorder, and variable dysmorphic features. This article presents the clinical and molecular characteristics of a 2-year-old male child with neurodevelopmental delay who was diagnosed with a chromosomal rearrangement due to a 15q24 duplication (dup15q24). The 15q24 locus presents controversy between the phenotype associated with duplication and deletion, thus posing a challenge in differential diagnosis for both. The phenotypes of autism spectrum disorder and pediatric patients with language delay should be evaluated by a multidisciplinary team comprising genetics, pediatrics, and pediatric neurology to shorten the diagnostic odyssey for patients with rare diseases and to impact the quality of life of the patient and their family.

14 July 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
DDDiana M. Dincã
Diana M. Dincã
LLLouison Lallemant
Louison Lallemant
AGAnchel González-Barriga
Anchel González-Barriga
NCNoémie Cresto
Noémie Cresto
SBSandra O. Braz
Sandra O. Braz
MGMário Gomes-Pereira
Mário Gomes-Pereira